Characterizing Pharmacokinetics in Children With Obesity-Physiological, Drug, Patient, and Methodological Considerations
Childhood obesity is an alarming public health problem. The pediatric obesity rate has quadrupled in the past 30 years, and currently nearly 20% of United States children and 9% of children worldwide are classified as obese. Drug distribution and elimination processes, which determine drug exposure...
Saved in:
Main Authors: | Jacqueline G. Gerhart (Author), Stephen Balevic (Author), Jaydeep Sinha (Author), Eliana M. Perrin (Author), Jian Wang (Author), Andrea N. Edginton (Author), Daniel Gonzalez (Author) |
---|---|
Format: | Book |
Published: |
Frontiers Media S.A.,
2022-03-01T00:00:00Z.
|
Subjects: | |
Online Access: | Connect to this object online. |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Physiologically‐based pharmacokinetic modeling of oxcarbazepine and levetiracetam during adjunctive antiepileptic therapy in children and adolescents
by: Jaydeep Sinha, et al.
Published: (2022) -
Profile of adalimumab and its potential in the treatment of uveitis
by: Balevic SJ, et al.
Published: (2016) -
Physiologically‐based pharmacokinetic modeling of pantoprazole to evaluate the role of CYP2C19 genetic variation and obesity in the pediatric population
by: Elizabeth J. Thompson, et al.
Published: (2024) -
External Evaluation of Risperidone Population Pharmacokinetic Models Using Opportunistic Pediatric Data
by: Eleni Karatza, et al.
Published: (2022) -
Use of physiologically‐based pharmacokinetic modeling to inform dosing of the opioid analgesics fentanyl and methadone in children with obesity
by: Jacqueline G. Gerhart, et al.
Published: (2022)